Achillion Pharma (ACHN)

6.34 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/19 *Est.)
- M&A (6/30/20 *Est)

Latest Headlines

Form 4 ACHILLION PHARMACEUTICAL For: Nov 14 Filed by: FISHERMAN JASON S November 14, 2019 6:47 PM - SEC Filing Form 4 ACHILLION PHARMACEUTICAL For: Nov 13 Filed by: Scheer David November 14, 2019 6:46 PM - SEC Filing Achillion Pharma (ACHN) Reports Clearance of Investigational New Drug Application for ACH-5228 November 11, 2019 7:33 AM - StreetInsider Achillion Announces Clearance of Investigational New Drug Application for ACH-5228 November 11, 2019 7:30 AM - Globe NewsWire Form 8-K ACHILLION PHARMACEUTICAL For: Nov 07 November 7, 2019 4:19 PM - SEC Filing Form DEFA14A ACHILLION PHARMACEUTICAL November 7, 2019 4:18 PM - SEC Filing Form 10-Q ACHILLION PHARMACEUTICAL For: Sep 30 November 7, 2019 4:08 PM - SEC Filing JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform Following Acquisition Offer November 7, 2019 12:40 PM - StreetInsider Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update November 7, 2019 7:30 AM - Globe NewsWire Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting November 6, 2019 9:07 AM - Globe NewsWire Form PREM14A ACHILLION PHARMACEUTICAL For: Nov 05 November 5, 2019 5:07 PM - SEC Filing Form 3/A ACHILLION PHARMACEUTICAL For: Feb 11 Filed by: Di Donato Brian November 1, 2019 4:23 PM - SEC Filing Form 4 ACHILLION PHARMACEUTICAL For: Oct 16 Filed by: Truitt Joseph October 18, 2019 5:14 PM - SEC Filing SVB Leerink Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform October 18, 2019 4:27 AM - StreetInsider Increasing unusual option volume: ACHN GOL LLNW CFG LX NSG GEL SOGO October 18, 2019 3:47 AM - StreetInsider Form DEFA14A ACHILLION PHARMACEUTICAL October 17, 2019 5:09 PM - SEC Filing Form DEFA14A ACHILLION PHARMACEUTICAL October 16, 2019 4:55 PM - SEC Filing Wedbush Positive on Alexion (ALXN) Amid Achillion Acquisition October 16, 2019 10:17 AM - StreetInsider Pre-Open Movers 10/16: (ACHN) (TECD) (SNBR) Higher; (PRQR) (RYTM) (WDAY) Lower (more...) October 16, 2019 9:25 AM - StreetInsider Form 8-K ACHILLION PHARMACEUTICAL For: Oct 15 October 16, 2019 8:54 AM - SEC Filing Form DEFA14A ACHILLION PHARMACEUTICAL October 16, 2019 8:52 AM - SEC Filing Alexion (ALXN) to Acquire Achillion (ACHN) for Initial Consideration of $6.30/Share in $930 Million Deal October 16, 2019 6:31 AM - StreetInsider Alexion to Acquire Achillion October 16, 2019 6:30 AM - BizWire Companies with NDRs 10/10 October 10, 2019 6:47 AM - StreetInsider Companies with NDRs 10/09 October 9, 2019 6:52 AM - StreetInsider Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference September 26, 2019 8:32 AM - Globe NewsWire Achillion Pharma (ACHN) Granted FDA Breakthrough Therapy Designation for Danicopan to Treat Paroxysmal Nocturnal Hemoglobinuria September 25, 2019 7:02 AM - StreetInsider Achillion Receives Breakthrough Therapy Designation from FDA for Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria September 25, 2019 7:00 AM - Globe NewsWire Form 8-K ACHILLION PHARMACEUTICAL For: Sep 13 September 17, 2019 4:06 PM - SEC Filing Achillion to Present at the Baird 2019 Global Healthcare Conference August 29, 2019 5:00 PM - Globe NewsWire Full Article List